The Lifetime Risk of Stroke: Estimates From the Framingham Study

Department of Neurology, School of Medicine, Boston University, Boston, MA 02118-2526, USA.
Stroke (Impact Factor: 5.72). 02/2006; 37(2):345-50. DOI: 10.1161/01.STR.0000199613.38911.b2
Source: PubMed


The lifetime risk (LTR) of stroke has not been reported for the United States population; such data would assist public education and health planning.
Framingham Original cohort participants (n=4897) who were stroke- and dementia-free at 55 years of age were followed biennially for up to 51 years (115 146 person years). We estimated the sex-specific 10-, 20-, and 30-year risks and LTR of developing a stroke by baseline age and blood pressure (BP) and compared it with the risk of developing Alzheimer disease (AD).
A total of 875 participants (522 women) developed a first-ever stroke; 749 (448 women) had an ischemic stroke. LTR of stroke was high and remained similar at ages 55, 65, and 75 years, approximating 1 in 5 for women and 1 in 6 for men. Participants with a normal BP (<120/80 mm Hg) had approximately half the LTR of stroke compared with those with high BP (> or =140/90 mm Hg). The LTR of AD at age 65 (292 participants; 211 women) approximated 1 in 5 for women and 1 in 10 for men. The LTR of developing either stroke or dementia approximated 1 in 3 in both sexes.
The LTR of stroke in middle-aged adults is 1 in 6 or more, which is equal to or greater than the LTR of AD. Women had a higher risk because of longer life expectancy. BP is a significant determinant of the LTR of stroke, and promotion of normal BP levels in the community might be expected to substantially reduce this risk.

Download full-text


Available from: Margaret Kelly-Hayes
  • Source
    • "A recent update published in the United States reported that each year, approximately 55,000 more women than men have a stroke. Furthermore, epidemiological studies claim that females have a higher lifetime risk of stroke than males, mainly among those 55–75 years of age with an incidence of 1 in 5 for women (20–21%) compared to 1 in 6 for men (14–17%) (Go et al., 2013; Kleindorfer et al., 2010; Seshadri et al., 2006). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Ethanol is an important risk factor for the occurrence of cerebral ischemia contributing to poor prognosis and inefficacy of drug treatments for stroke-related symptoms. Females have a higher lifetime risk for stroke than males. Moreover, female gender has been associated with increased ethanol consumption during adolescence. In the present study, we investigated whether chronic ethanol exposure during adolescence may potentiate the motor impairments and cortical damage induced by focal ischemia in female rats. We also addressed whether these effects can be mitigated by minocycline, which has been shown to be neuroprotective against different insults in the CNS. Female rats were treated with distilled water or ethanol (6.5 g/kg/day, 22.5% w/v) for 55 days by gavage. Focal ischemia was induced by microinjections of endothelin-1 (ET-1) into the motor cortex. Animals of both groups were treated daily with minocycline (25 to 50 mg/kg, i.p.) or sterile saline (i.p.) for five days, and motor function was assessed using open field, inclined plane and rotarod tests. Chronic ethanol exposure exacerbated locomotor activity and motor coordination impairments induced by focal ischemia in rats. Moreover, histological analysis revealed that microinjections of ET-1 induced pyramidal neuron loss and microglial activation in the motor cortex. Minocycline reversed the observed motor impairments, microglial activation and pyramidal neuron loss in the motor cortex of ischemic rats even in those exposed to ethanol. These results suggest that minocycline induces neuroprotection and functional recovery in ischemic female rats intoxicated with ethanol during adolescence. Furthermore, the mechanism underlying this protective effect may be related to the modulation of neuroinflammation.
    Full-text · Article · May 2014 · Brain research
  • Source
    • "In addition to acting on preventable risk factors [18], the strategy of increasing stroke awareness has often been employed to reduce pre-hospital delays, both in the general population and in BME communities. A recent review showed that awareness of symptoms of stroke is low in the general population, and tends to be poorer in ethnic communities [19]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Stroke places a significant burden to all affected individuals, but it is perhaps more significant amongst members of black, minority and ethnic communities, who may experience poorer awareness of stroke symptoms than the general population. Recently, several initiatives tried to improve public awareness that symptoms of stroke need to be treated as a medical emergency. However, ethnic communities present cultural barriers, requiring tailored health promotion interventions, whose effectiveness remains uncertain. Our systematic review aimed to identify relevant published evidence, synthesize the main study components and identify evidence of the effectiveness of the interventions. MEDLINE, EMBASE, CINAHL, and PsycInfo were searched for journal articles on health promotion interventions for increasing stroke awareness in ethnic minorities, published in English between 1995 and 2012. Search results were collaboratively assessed by the authors; included studies were analysed to identify their main characteristics, and a thematic analysis of their content was conducted. No meta-analysis was performed, due to the heterogeneity of results. Eighteen studies were included, reporting 15 interventions conducted in the US, for African-Americans or Hispanics; populations sizes differed between interventions. Interventions were mostly carried out in community settings with different educational techniques, focussing on experiential methods. Health professionals usually organized the programs, delivered by nurses, other health professionals or volunteers.The few theory-based interventions focussed on individual-level behavioural change. Practical cultural adaptation strategies were not linked to specific theoretical frameworks. Interventions widely differed as for target populations, settings, delivery methods, contents and professional roles involved. All study designs were quantitative, and the emerging evidence of effectiveness was inconclusive.Such interventions operate in very complex scenarios, and several variables may influence their effectiveness. Therefore, qualitative or mixed-methods study designs may shed light on barriers and facilitators, experiential education strategies and community involvement.Network- and community-level theories may help improving design and evaluation of interventions. Eleven case reports and four RCTs provide evidence about stroke awareness interventions organized in the US. The studies provide only partial and inconclusive evidence about the effectiveness of the interventions. Hence, further research is needed on different countries and ethnic minorities.
    Full-text · Article · Apr 2014 · BMC Public Health
  • Source
    • "Women not only have a higher risk of developing AD than age-matched men such as higher numbers of female AD patients than male patient with AD (Vina and Lloret, 2010; Aronson et al., 1990; Gao et al., 1998; Jorm et al., 1987), but also showed significantly age-related faster decline and greater deterioration of cognition than elderly male (Proust-Lima et al., 2008; Read et al., 2006; Henderson and Buckwalter, 1994). Furthermore, both neuroimaging and postmortem human studies showed difference AD pathology in men and women, such as men with AD had more pronounced pathology in right hemisphere where women with AD often had more manifest pathology than that in male AD patients (Seshadri et al., 2006; Phung et al., 2010). Although clear gender differences have been reported in the incidence and prevalence of dementia (De Deyn et al., 2011 "
    [Show abstract] [Hide abstract]
    ABSTRACT: Studies have shown differences in specific cognitive ability domains and risk of Alzheimer's disease between the men and women at later age. However it is important to know that sex differences in cognitive function during adulthood may have their basis in both organizational effects, i.e., occurring as early as during the neuronal development period, as well as in activational effects, where the influence of the sex steroids influence brain function in adulthood. Further, the rate of cognitive decline with aging is also different between the sexes. Understanding the biology of sex differences in cognitive function will not only provide insight into Alzheimer's disease prevention, but also is integral to the development of personalized, gender-specific medicine. This review draws on epidemiological, translational, clinical, and basic science studies to assess the impact of sex differences in cognitive function from young to old, and examines the effects of sex hormone treatments on Alzheimer's disease in men and women.
    Full-text · Article · Jan 2014 · Frontiers in Neuroendocrinology
Show more